Decision Intelligence Boutique · Saudi Arabia & GCC

We build decision systems healthcare leaders can trust.

HealthElevate provides structured Decision Instruments for executives facing high-stakes, difficult-to-reverse choices: before those choices become irreversible.

Explore Our Instruments Read Our Insights

Decision Assurance for High-Stakes Healthcare

We are not a consulting firm, an analytics vendor, or an AI company. HealthElevate operates above vendors and below boards – providing independent analytical judgment through proprietary Decision Instruments when it matters most.

Decision Instruments

A growing suite of proprietary instruments across VBHC readiness, AI governance, population health, reimbursement reform, FWA governance, market access, and more – each delivering a clear Proceed, Delay, or Redesign recommendation.

Independent Analysis

Every engagement is grounded exclusively in publicly available data: vendor-neutral, COI-protected, and designed to withstand board-level scrutiny. Our independence is the value.

Board-Ready Outputs

Every engagement concludes with a structured written brief: section-by-section risk analysis, an explicit Proceed / Delay / Redesign recommendation, and a summary ready for executive or board presentation.

Why Decision Rigour Matters Here

Saudi Arabia's healthcare transformation is operating at speed. The decisions being made now – on VBHC contracting, AI deployment, insurance reform, and population health – will shape the system's performance through 2030 and beyond.

SAR 140B
Insurance market growth targeted by the National Insurance Sector Strategy (NISS) through 2030
SAR 3.5B+
Annual preventable claims losses in Saudi healthcare – largely process failures, not fraud
SAR 40–65B
Potential annual savings from successful VBHC implementation by 2035 (PwC estimate)
5.88%
Current AI adoption rate in Saudi hospitals – despite active procurement across the sector

One Suite. One Purpose.

Each instrument addresses a specific high-stakes healthcare decision. Every output delivers a structured Proceed / Delay / Redesign recommendation supported by evidence-backed analysis.

Independent Analysis of Saudi Healthcare Reform

View All Insights
Insurance Reform
The NISS Expansion: What Scaling to 23 Million Beneficiaries Actually Requires
The NISS reimbursement reform, AR-DRG transition, and NPHIES integration arrive simultaneously. Most organisations are preparing for one of three concurrent pressures: not all three at once.
April 2026 · 6 min Read →
AI Governance
AI Deployment in Saudi Healthcare: Why the Governance Gap Is the Real Risk
Saudi Arabia has world-leading AI device regulation. The accountability gap sits at the deployment decision level – and most organisations have not addressed it.
April 2026 · 6 min Read →
VBHC & Contracting
Value-Based Healthcare in Saudi Arabia: The Outcome Measurement Gap
Saudi VBHC contracts are failing in a predictable three-year cycle. Measuring outcomes and contracting on them are not the same discipline.
April 2026 · 6 min Read →
Reimbursement Reform
AR-DRG Adoption in Saudi Arabia: What the Reimbursement Shift Requires from Providers and Insurers
38% of Saudi providers are not yet prepared for DRG coding. The question is not whether to transition: it is whether your organisation can absorb the shift without a cash-flow or pricing crisis in year one.
April 2026 · 8 min Read →
Regulatory Governance
Risk-Based Capital and the Insurance Authority: What Saudi Insurers Must Restructure Before 2027
RBC pilot 2026, mandatory January 2027 – arriving simultaneously with NISS expansion, AR-DRG transition, and a consolidated Insurance Law. The compounded risk for health insurers is the analytical story.
April 2026 · 9 min Read →

Who We Work With

HealthElevate is designed for healthcare leaders who carry decision responsibility: not those who study decisions from a distance.

Chief Financial Officers

Revenue resilience, VBHC contract risk, denial exposure, and cash-flow stress testing under payment reform.

Chief Operating Officers

Change-readiness, integrated care capability, digital health scale-up risk, and population health programme launches.

Chief Medical Officers

AI deployment governance, clinical decision safety, FWA structural exposure, and care pathway integrity.

VBHC & VBC Programme Directors

Contract stress testing, readiness sequencing, failure-mode identification, and regulatory shock scenarios.

Board Members & Non-Executives

Board-level decision safety reviews, irreversibility assessments, and governance gate approvals for major commitments.

National Transformation Leaders

System-level analytical work aligned to Vision 2030, CNHI capitation reform, NPHIES integration, and PHM programme scale-up.

Structured Analytical Support. Precisely Scoped.

Every engagement begins with a focused scoping conversation to confirm the decision context and identify the right instrument. Three tiers are available – from a rapid single-instrument brief to a coordinated programme diagnostic.

All engagements are structured around specific decision contexts, not open-ended retainers. Every tier delivers a written Proceed / Delay / Redesign recommendation with clear scope and defined timeline.

View Engagement Details

Ready to bring rigour to your next critical decision?

Every engagement begins with a focused conversation about your specific decision context. No open-ended retainers. No jargon. Structured analytical support, precisely scoped.

Request a Diagnostic